Misappropriation and Poor Accountability of Controlled Medications
Penalty
Summary
The deficiency involves the facility’s failure to protect residents from misappropriation of medications, specifically controlled substances, and to ensure accurate administration and documentation for three residents. For one resident with chronic pain, muscle spasm, spinal stenosis, osteoarthritis, hypertension, and Alzheimer’s disease, the MDS showed moderate cognitive impairment and ongoing pain requiring scheduled Morphine Sulfate ER 15 mg twice daily. On the date in question, an incident report documented that the DON was notified that this resident and others had not received their scheduled 9:00 AM narcotic medications. The narcotic book showed that an LPN had signed out the Morphine as if administered, but the resident later verbalized that the morning dose had not been received. For a second resident with cerebral infarction, vertebral fracture, arthritis, and hypertension, the MDS indicated moderate cognitive impairment and frequent, almost constant pain that interfered with daily activities, with an order for Tramadol 50 mg twice daily. The incident report again showed that the DON was notified that this resident had not received the scheduled 9:00 AM narcotic medication, while the narcotic book reflected that the LPN had signed out the Tramadol as administered. Review of the MAR for that date revealed conflicting pain scores of 0 and 9 and showed Tramadol initialed as given at 9:00 AM, but there was no documentation of the actual time of administration or explanation for the delayed or missed dose. A progress note indicated that Tramadol was signed out in the narcotic book but not signed off on the MAR. For a third resident with major depressive disorder, anxiety, gout, and psoriasis, the MDS showed little to no cognitive impairment and frequent pain, and the resident had an order for Alprazolam 0.5 mg once daily for anxiety. The incident report documented that the DON was notified that this resident had not received the scheduled 9:00 AM anxiety medication, even though the narcotic book showed the LPN had signed out the Alprazolam as if given. The MAR showed Alprazolam initialed as administered at 9:00 AM, but there was no documentation of the actual time of administration or any accounting for the delayed or missed dose. Progress notes for this resident stated that the medication was not signed off on the EMAR but was signed off in the narcotic book as given at 9:00 AM. Across all three residents, the LPN initially confirmed administration of the medications but later stated that, after being asked to leave the facility because she was not formally assigned to the shift, she discarded the medications without a witness, contrary to facility policy requiring two licensed staff to witness and document any controlled substance disposal. The facility’s written policy on Controlled Substance Administration & Accountability stated that the Controlled Drug Record serves the dual purpose of recording both narcotic disposition and patient administration and, together with the MAR, is the source for documenting any patient-specific narcotic dispensed from the pharmacy. The policy also required that two licensed staff witness any disposal or destruction of a controlled substance and document it on the Drug Disposition Record. In these incidents, controlled substances were signed out in the narcotic log as if administered, residents reported or were documented as having missed or late doses, and there was no proper witnessing or documentation of disposal, resulting in discrepancies between the narcotic log, MAR, and resident reports.
We Help Long-Term Care Teams Stay Survey-Ready
We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.